Sanguine Chemie Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.10 M
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 2.69 M
- Revenue Growth -47.40%
- Profit Growth -28.20%
- Ebitda 103.75%
- Net Worth 0.69%
- Total Assets 138.92%
About Sanguine Chemie
Sanguine Chemie Private Limited (SCPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 January 2012 and has a history of 13 years and one month. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.10 M.
The company currently has active open charges totaling ₹2.69 M.
Murugesan Kumar and Ramesh Deepalakshmi serve as directors at the Company.
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100TN2012PTC083872
- Company No.
083872
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2012
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Sanguine Chemie?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murugesan Kumar  | Director | 04-Jan-2012 | Current |
| Ramesh Deepalakshmi | Director | 04-Jan-2012 | Current |
Financial Performance of Sanguine Chemie.
Sanguine Chemie Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 47.4% decrease. The company also saw a substantial fall in profitability, with a 28.2% decrease in profit. The company's net worth moved up by a moderate rise of 0.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanguine Chemie?
In 2019, Sanguine Chemie had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.69 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.27 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Dec 2012 | Others | ₹2.69 M | Open |
How Many Employees Work at Sanguine Chemie?
Unlock and access historical data on people associated with Sanguine Chemie, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanguine Chemie, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanguine Chemie's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.